C12Y 302/01048
Sucrose alpha-glucosidase , i.e. sucrase
Official title: Sucrose alpha-glucosidase (3.2.1.48), i.e. sucrase
C12Y302/01048 (Sucrose alpha-glucosidase , i.e. sucrase) appears on 6 US grants and 13 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 13
- Assignees
- 10
- Inventors
- 35
- Latest grant
- 25 Jul 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 3 |
| 2012 | 2 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 2 | 3 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Double stranded RNA constructs for aphid control25 Jul 2017US 9,714,425 B2The United States of America as represented by the Secretary of Agriculture
- Double stranded RNA constructs for aphid control28 Feb 2017US 9,580,709 B2The United States of America as represented by the Secretary of Agriculture
- Microorganisms for producing L-amino acids and process for producing L-amino acids using them5 Nov 2013US 8,574,874 B2Cj Cheiljedang Corporation
- Foodstuff comprising an extract of a plant of the genus Salacia and flavonoid24 Jul 2012US 8,226,991 B2FUJIFILM Corporation
- Recombinant bacteria having the ability to metabolize sucrose6 Mar 2012US 8,129,170 B1E. I. Du Pont de Nemours and Company
- Methods and compositions for treating congenital sucrase-isomaltase deficiency8 Jan 2026US 2026/0009011 A1Anagram Therapeutics, Inc.
- Methods and compositions for treating congenital sucrase-isomaltase deficiency31 Jul 2025US 2025/0243475 A1Anagram Therapeutics, Inc.
- Engineered immune cell13 Feb 2025US 2025/0049917 A1King's College London
- Composition of digestive enzymes and appetite suppressants19 Mar 2020US 2020/0086147 A1
- Protease compositions for use in modifying semen14 Dec 2017US 2017/0354594 A1
Most cited
By later US patents